Polypharmacy in multimorbid older adults: protocol for a systematic review

被引:0
作者
Caroline Sirois
Marie-Laure Laroche
Line Guénette
Edeltraut Kröger
Dan Cooper
Valérie Émond
机构
[1] Laval University,Department of Social and Preventive Medicine, Faculty of Medicine
[2] Centre de recherche du CHU de Québec,Centre d’excellence sur le vieillissement de Québec
[3] Institut national de santé publique du Québec,Santé des populations et pratiques optimales en santé
[4] Centre de recherche du CHU de Québec,Service de Pharmacologie, Toxicologie et Pharmacovigilance, Centre Régional de Pharmacovigilance, de Pharmacoépidémiologie et d’information sur les médicaments
[5] Centre Hospitalier Universitaire de Limoges,Faculté de Médecine
[6] Université de Limoges,Faculté de pharmacie
[7] Université Laval,Centre d’excellence sur le vieillissement de Québec
[8] Hôpital du St-Sacrement,undefined
来源
Systematic Reviews | / 6卷
关键词
Older adults; Polypharmacy; Multimorbidity; Prescription drugs; Chronic diseases; Surveillance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 74 条
  • [1] Patterson SM(2012)Interventions to improve the appropriate use of polypharmacy for older people Cochrane Database Syst Rev 5 CD008165-995
  • [2] Hughes C(2012)Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes J Clin Epidemiol 65 989-1523
  • [3] Kerse N(2006)Polypharmacy and prescribing quality in older people J Am Geriatr Soc 54 1516-450
  • [4] Cardwell CR(1996)Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population Am J Emerg Med 14 447-918
  • [5] Bradley MC(2007)The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register Drug Saf 30 911-393
  • [6] Gnjidic D(2010)Comorbidity in the elderly with diabetes: identification of areas of potential treatment conflicts Diabetes Res Clin Pract 87 385-1959
  • [7] Hilmer SN(2004)Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 164 1957-316
  • [8] Blyth FM(2007)Polypharmacy and the balance of medication benefits and risks Am J Geriatr Pharmacother 5 314-172
  • [9] Naganathan V(2012)Factors leading to excessive polypharmacy Clin Geriatr Med 28 159-351
  • [10] Waite L(2007)Polypharmacy in elderly patients Am J Geriatr Pharmacother 5 345-132